Press Releases 2007
Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
S.T.A.R. Program Brings Together Researchers from North America's Leading Prostate Cancer Centers
Washington, DC, November 15, 2007 – Safeway Inc. and the Prostate Cancer Foundation today announced they will collectively donate $6 million to fund the S.T.A.R. Program (for Special Team Amplification of Research), an innovative research initiative focused on exploring the role of targeted heat in cancer therapy to treat prostate cancer, as well as other research strategies.
Leading Researchers to Reveal Comprehensive Dos and Don'ts for Prostate Cancer
Avoiding Prostate Cancer and Living Better after Diagnosis Subject of "Lifestyle" Panel
Lake Tahoe, CA, October 13, 2007 – Lake Tahoe, CA, October 13, 2007–Today at the Prostate Cancer Foundation's Annual Scientific Retreat, researchers will share new findings on how eating common foods such as tomatoes and fish, maintaining a healthy weight, and avoiding meats cooked at high temperatures may help prevent prostate cancer, and help men live healthier and longer after diagnosis. One in six men will be diagnosed with prostate cancer in their lifetime, and an estimated 218,890 cases will occur in The United States this year.
David H. Koch – Prostate Cancer Foundation Nano-Medicine Gift Announced
$5 Million Award Creates Collaborative Team Across Four Leading Research Institutions
Lake Tahoe, CA, October 12, 2007 – One of the largest-ever individual donations for prostate cancer research will unite researchers across institutions and disciplines in the field of nanotechnology. This research team, created by the Prostate Cancer Foundation, will seek to develop a novel nano-medicine that can be given intravenously and delivered directly to targeted prostate tumors. The five million dollar gift by philanthropist and business leader David H. Koch was announced at the Foundation's Annual Scientific Retreat.
New Molecules Discovered that Block Cancer Cells from Modifying Cell DNA
Lake Tahoe, CA, October 11, 2007 – Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications. The findings were presented today at the Prostate Cancer Foundation's annual Scientific Retreat. Funding for the research was provided by the Prostate Cancer Foundation, as well as from the National Cancer Institute and the Avon Foundation.
New Research May Show Why Some Prostate Cancer Recurs After Treatment
Cancer Cells Contain Building Blocks for Cancer "Fuel"
Lake Tahoe, CA, October 11, 2007 – Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth. New research has now detected that androgen-synthesizing proteins are present within cancer cells, which suggests that cancer cells may develop the capacity to produce their own androgens.
New Genetic Cause Identified in Prostate Cancer Development
Research Studies Funded by Prostate Cancer Foundation Help Find a Master "On" Switch for Prostate Cancer
SANTA MONICA, Calif., August 6, 2007 – Data from a new study implicates a specific genetic change as an underlying cause of prostate cancer development, according to a report published August 1, 2007, in Nature. The finding revealed that prostate cancer really is a set of different cancers that are "turned on" by a common "master switch" gene.
Safeway Customers and Employees Join Together to Raise Record $10.7 Million to Help Find a Cure for Prostate Cancer
PLEASANTON, Calif. — July 16, 2007 — Safeway shoppers and employees joined together in the month of June to raise a record $10.7 million to fund critical research programs aimed at finding a cure for prostate cancer. By making donations when shopping at local stores, the fundraising program is making a huge impact, raising $28 million since it began in 2000.
Athletes TEAM Up in the Fight Against Prostate Cancer
Prostate Cancer Foundation Launches National Campaign To Encourage Better Patient Care
SANTA MONICA, Calif., May 8, 2007 – The Prostate Cancer Foundation announced today the launch of a national public service campaign encouraging men with prostate cancer to seek the advice of an integrated team of health care professionals – a urologist, a radiation oncologist and a medical oncologist – to optimize their treatment. As part of the fundraising and awareness effort called Athletes for a Cure, the new campaign will consist of television and radio PSAs featuring nationally-recognized sportscaster Trey Wingo, as well as other Athletes touched by prostate cancer.
Prostate Cancer Foundation Awards $6.1 Million to Record Number of Competitive Award Recipients
SANTA MONICA, Calif., March 2, 2007 – The Prostate Cancer Foundation (PCF) announced today the recipients of the its 2006 Competitive Awards Program. The program granted a total of $6.1 million to 63 research investigators from four counties, of whom 30 were first-time awardees.
Prostate Cancer Foundation Appoints Executive to Oversee Discovery and Translational Research
Howard R. Soule, PhD, rejoins the PCF after two-year sabbatical to lead innovative research efforts
SANTA MONICA, Calif., February 23, 2007 — The Prostate Cancer Foundation (PCF) has announced the appointment of Howard R. Soule, PhD as Executive Vice President, Discovery and Translation.
Prostate Cancer Foundation Donors Exceed Matching Grant, Raise $1.5 Million
Funds from the Wade F. B. Thompson Matching Grant will provide needed resources to investigators as they aggressively search for better treatments and a cure for prostate cancer
SANTA MONICA, Calif., February 12, 2007 – More than 8,500 Prostate Cancer Foundation (PCF) donors generously contributed $755,000 to the Wade F. B. Thompson Matching Grant, exceeding the $500,000 goal. Thompson matched the entire amount, resulting in a total of more than $1.5 million raised for prostate cancer research.
| 
